Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
CVS · NYSE · Pharmacy & insurance
$81.35−4.46 (−5.20%)
Close of Nov 18, 2026, vs Nov 17 · end-of-day, not a live quote
CVS Health (CVS) · oqro.io/stocks/CVS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Viking Global no longer reported CVS for Q3 2026SourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 16, 2026
Bridgewater Associates disclosed a reduced position in CVS for Q3 2026SourceInsider trade · Traded Nov 6, 2026 · Filed Nov 6, 2026
Officer purchased ~$2M of CVS shares in the open marketSourceFederal contract · Signed Sep 25, 2026 · Updated Sep 25, 2026
Department of Health and Human Services awarded CVS Health: $6.99M obligated to dateSourceFederal contract · Signed Apr 1, 2026 · Updated Aug 17, 2026
Department of Veterans Affairs awarded CVS Health: $204K obligated to dateSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Glenview Capital Management, LLC disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Alyeska Investment Group, L.P. disclosed a new position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Viking Global disclosed a new position in CVS for Q2 2026Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 31, 2026
Mn Services Vermogensbeheer B.V. disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 30, 2026
Saudi Central Bank disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
Munich Reinsurance Co Stock Corp in Munich disclosed a new position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 24, 2026
LBP Am SA disclosed an increased position in CVS for Q2 2026Fund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 29, 2026
Perceptive Advisors LLC no longer reported CVS for Q1 2026SourceInsider trade · Traded May 20, 2026 · Filed May 21, 2026
Director sold ~$74.6M of CVS shares in the open marketSourceInsider trade · Traded May 21, 2026 · Filed May 21, 2026
Director sold ~$34.6M of CVS shares in the open marketSourceInsider trade · Traded May 21, 2026 · Filed May 21, 2026
Director sold ~$35.3M of CVS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 28, 2026
BW Gestao de Investimentos Ltda. no longer reported CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 24, 2026
Pzena Investment Management LLC disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 22, 2026
Canoe Financial LP disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 22, 2026
Fort Washington Investment Advisors Inc disclosed an increased position in CVS for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Maple Rock Capital Partners Inc. disclosed a new position in CVS for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Samlyn Capital, LLC disclosed a new position in CVS for Q4 2025SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Hotchkis & Wiley Capital Management LLC no longer reported CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Samlyn Capital, LLC no longer reported CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Maple Rock Capital Partners Inc. disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bellevue Group AG disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Lord, Abbett & Co. LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Worldquant Millennium Advisors LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Susquehanna Portfolio Strategies, LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Shelton Capital Management disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Brandes Investment Partners, LP disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Holocene Advisors, LP disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Freestone Grove Partners LP disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Ariel Investments, LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Silvercrest Asset Management Group LLC disclosed a reduced position in CVS for Q2 2026Source5%+ stake · Stake as of Jun 30, 2026 · Filed Aug 13, 2026
Dodge & Cox cut its CVS stake below 5% (3.9%)SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Dodge & Cox disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Letko, Brosseau & Associates Inc disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Epoch Investment Partners, Inc. disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 13, 2026
Clearbridge Investments, LLC disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
GQG Partners LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Capital World Investors disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Capital International, Inc. disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Capital Research Global Investors disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
NorthCoast Asset Management LLC disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 12, 2026
Storebrand Asset Management AS disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Davis Selected Advisers disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
South Dakota Investment Council disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Vaughan David Investments LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 11, 2026
Advisors Capital Management, LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 7, 2026
Pzena Investment Management LLC disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 6, 2026
LSV Asset Management disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 4, 2026
Todd Asset Management LLC no longer reported CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 4, 2026
SEB Asset Management AB disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 23, 2026
Mediolanum International Funds Ltd disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 21, 2026
Robeco Institutional Asset Management B.V. disclosed a reduced position in CVS for Q2 2026SourcePolitician trade (Senate) · Transaction Mar 27, 2026 · Disclosed Jul 21, 2026
Disclosed purchase of CVS — reported range $1,001 - $15,000SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 20, 2026
Gateway Investment Advisers LLC disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 17, 2026
Fort Washington Investment Advisors Inc disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 16, 2026
Canoe Financial LP disclosed an increased position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 14, 2026
Douglas Lane & Associates, LLC disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 10, 2026
Wedge Capital Management L L P disclosed a reduced position in CVS for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Jul 7, 2026
Hamlin Capital Management, LLC disclosed an increased position in CVS for Q2 2026SourceInsider trade · Traded May 19, 2026 · Filed May 21, 2026
Director sold ~$187M of CVS shares in the open marketSourceInsider trade · Traded May 20, 2026 · Filed May 21, 2026
Director sold ~$14.5M of CVS shares in the open marketSourceInsider trade · Traded May 20, 2026 · Filed May 21, 2026
Director sold ~$6.4M of CVS shares in the open marketSourceInsider trade · Traded May 20, 2026 · Filed May 21, 2026
Director sold ~$77K of CVS shares in the open marketSourceInsider trade · Traded May 19, 2026 · Filed May 21, 2026
Director sold ~$14K of CVS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Maple Rock Capital Partners Inc. disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
SRS Investment Management, LLC no longer reported CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Sachem Head Capital Management LP no longer reported CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Samlyn Capital, LLC disclosed a reduced position in CVS for Q1 2026SourcePolitician trade (House) · Transaction Nov 21, 2025 · Disclosed May 15, 2026
Disclosed partial sale of CVS — reported range $1,001 - $15,000SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Brandes Investment Partners, LP disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Shelton Capital Management disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Freestone Grove Partners LP disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Holocene Advisors, LP disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Saudi Central Bank disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Hotchkis & Wiley Capital Management LLC disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Silvercrest Asset Management Group LLC disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Dodge & Cox disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Epoch Investment Partners, Inc. disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
Ariel Investments, LLC disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 14, 2026
British Columbia Investment Management Corp disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
NorthCoast Asset Management LLC disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
Capital International Investors disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
Capital World Investors disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 13, 2026
Capital International, Inc. disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Todd Asset Management LLC disclosed a new position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Vaughan David Investments LLC disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 12, 2026
Tocqueville Asset Management L.P. disclosed a reduced position in CVS for Q1 2026SourceInsider trade · Traded May 8, 2026 · Filed May 11, 2026
Officer sold ~$6.23M of CVS shares in the open marketSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 7, 2026
Davis Selected Advisers disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 6, 2026
Mediolanum International Funds Ltd disclosed an increased position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 21, 2026
Robeco Institutional Asset Management B.V. disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 15, 2026
Douglas Lane & Associates, LLC disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 14, 2026
Hamlin Capital Management, LLC disclosed a reduced position in CVS for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed Apr 13, 2026
Wedge Capital Management L L P disclosed an increased position in CVS for Q1 2026Source